|
HY-D1542-1g
|
MedChemexpress LLC
|
Mu cicarmine [CAS 51395-97-2]
|
|
|
|
|
HY-D1542-5g
|
MedChemexpress LLC
|
Mu cicarmine [CAS 51395-97-2]
|
|
|
|
|
HY-D1542-500mg
|
MedChemexpress LLC
|
Mu cicarmine [CAS 51395-97-2]
|
|
|
|
|
HY-P77093-10ug
|
MedChemexpress LLC
|
Mu STN1, Human (His)
|
|
|
|
|
HY-P77093-100ug
|
MedChemexpress LLC
|
Mu STN1, Human (His)
|
|
|
|
|
HY-P77093-5ug
|
MedChemexpress LLC
|
Mu STN1, Human (His)
|
|
|
|
|
HY-P77093-50ug
|
MedChemexpress LLC
|
Mu STN1, Human (His)
|
|
|
|
|
HY-P77093-500ug
|
MedChemexpress LLC
|
Mu STN1, Human (His)
|
|
|
|
|
HY-P700877-100ug
|
MedChemexpress LLC
|
MXRA8, Mouse (HEK293, His)
|
|
|
|
|
HY-P700877-20ug
|
MedChemexpress LLC
|
MXRA8, Mouse (HEK293, His)
|
|
|
|
|
HY-P700877-50ug
|
MedChemexpress LLC
|
MXRA8, Mouse (HEK293, His)
|
|
|
|
|
HY-P1821A-10mg
|
MedChemexpress LLC
|
Myelin Basic Protein (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1821A-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W008956-10mg
|
MedChemexpress LLC
|
Myoseverin [CAS 267402-71-1]
|
|
COVID-19-anti-virus
|
|
|
HY-W008956-100mg
|
MedChemexpress LLC
|
Myoseverin [CAS 267402-71-1]
|
|
COVID-19-anti-virus
|
|
|
HY-W008956-25mg
|
MedChemexpress LLC
|
Myoseverin [CAS 267402-71-1]
|
|
COVID-19-anti-virus
|
|
|
HY-W008956-5mg
|
MedChemexpress LLC
|
Myoseverin [CAS 267402-71-1]
|
|
COVID-19-anti-virus
|
|
|
HY-W008956-50mg
|
MedChemexpress LLC
|
Myoseverin [CAS 267402-71-1]
|
|
COVID-19-anti-virus
|
|
|
HY-W008956-1mL
|
MedChemexpress LLC
|
Myoseverin [CAS 267402-71-1] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-125039-1mg
|
MedChemexpress LLC
|
N-Acetyl lysyltyrosylcysteine amide [CAS 1287585-40-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-125039-10mg
|
MedChemexpress LLC
|
N-Acetyl lysyltyrosylcysteine amide [CAS 1287585-40-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-125039-5mg
|
MedChemexpress LLC
|
N-Acetyl lysyltyrosylcysteine amide [CAS 1287585-40-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-125039-1mL
|
MedChemexpress LLC
|
N-Acetyl lysyltyrosylcysteine amide [CAS 1287585-40-3] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-17639-1mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-17639-10mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
